Medical ghost-writing

Mens Sana Monographs

Volumn 6, Issue 1, 2008, Pages 257-273

  Langdon Neuner, Elise ^a,b  

^a European Medical Writers Association

^b NONE   (Austria)

Author keywords

Acknowledgement; Author.s editor; Ghost authorship; Ghost writing; Pharmaceutical industry; Publication ethics

Indexed keywords

EID: 44249115875     PISSN: 09731229     EISSN: 19984014     Source Type: Journal    
DOI: 10.4103/0973-1229.33006     Document Type: Article

References (37)

1. Barnett A., (2003), Revealed: how drug firms 'hoodwink' medical journals. Available from: http://observer.co.uk/uk_news/story/0,6903,1101680,00.html. [Last accessed in 2007 Apr].
2. Bhopal R., Rankin J., McColl E., Thomas L., Kaner E., Stacy R., et al., (1997), The vexed question of authorship: views of researchers in a British medical faculty, BMJ, 314, p1009-1012.
3. Chalmers I., (2008), Role of systematic reviews in detecting plagiarism: case of Asim Kurjak (Review), BMJ, 333:7568, p594-596.
4. Chaudhry S., Sehroter S., Smith R., Morris J., (2002), Does declaration of competing interests affect reader perceptions? A randomised trial, BMJ, 325, p1391-1392.
5. Dawes K., (2007), Ghostwriters need to be more visible, BMJ, 34, p208.
6. ICMJE, (2006), II.A Authorship and Contributorship. In: Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Available from: http://www.icmje.org [Last accessed on 2007 May 2].
7. Flanagin A., Carey L.A., Fontanarosa P.B., Phillips S.G., Pace B.P., Lundberg G.D., et al., (1998), Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals, JAMA, 280:3, p222-224.
8. Fugh-Berman A., (2005), The Corporate Coauthor, J Gen Intern Med, 20, p546-548.
9. Gøtzsehe P.C., Hróbjartsson A., Johansen H.K., Haahr M.T., Altman D.G., Chan A-W., (2007), Ghost Authorship in Industry-Initiated Randomised Trials, PloS Med, 4, e535-doi:10.1371/journal.pmed.0040535
10. Griffin-Sobel J.P., (2005), The status of peer review, (Editorial), Clin J Oncol Nursing, 9, p669.
11. Hamilton C.W., Royer M.S., (2003), AMWA position statement on the contributions of medical writers to scientific publications, AMWA Journal, 18(1), p13-16.
12. Hamilton C.W., Jacobs A., (2006), Survey of AMWA and EMWA members who make substantial contributions to manuscripts (poster 3), AMWA Journal, 21(2), p50.
13. Healy D., Cattell D., (2003), Interface between authorship, industry and science in the domain of therapeutics, B J Psychiatry, 183, p22-27.
14. Healy D.T., (2004), Transparency and trust figure for ghost written articles was misquoted, (Letter), BMJ, 329, p1345.
15. Holden C., (2006), Science publishing. The undisclosed background of a paper on depression treatment (News), Science, 313, p598.
16. Jacobs A., Wager E., (2005), European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications, Curr Med Res Opin, 21:2, p317-321.
17. Jirik K., (2000), How Great researchers Get By-lines, Get Paid and Get medicine in Trouble. Available from: http://www.bioethicsforum.org/plagiarism- in-medical-research.asp. [Last accessed on 2007 Apr].
18. Krumholz H.M., Ross J.S., Presler A.H., Egilman D.S., (2007), What have we learnt from Vioxx? BMJ, 334, p120-123.
19. Laine C., (2005), Exorcising Ghosts and Unwelcome Guests, (Editorial), Ann Intern Med, 143:8, p611-612.
20. Larkin M., (1999), Whose article is it anyway? Lancet, 354, p136.
21. Lenzer J., (2003), Whistleblower charges drug company with deceptive practices, BMJ, 326, p620.
22. Madsen S., (2005), Ghostwriters- hide your tracks, (Letter), BMJ. Available from: http://bmj.bmjjournals.com/cgi/eletters/330/7498/988-a [Last accessed in 2007 Apr].
23. Moffatt B., Elliott C., (2007), Ghost Marketing, Perspectives in Biology and Medicine, 50, p18-31.
24. Mowatt G., Shirran L., Grimshaw J.M., Rennie D., Flanigan A., Yank V., et al., (2002), Prevalence of honorary and ghost authorship in Cochrane reviews, JAMA, 287, p2769-2771.
25. Nemeroff C.B., Mayberg H.S., Krahl S.E., McNamara J., Frazer A., Henry T.R., et al.,(2006), VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms, Neuropsychopharmacology, 31, p1345-1355.
26. Rees S., (2003), Who actually wrote the research paper? How to find it out (Letter), BMJ, Available from: http://bmj.bmjjournals.com/cgi/ eletters/326/7400/1202. [Last accessed in 2007 Apr].
27. Rennie D., (1997), When Authorship fails. A proposal to make contributors accountable, JAMA, 278, p579-585.
28. Select Committee on Health. House of Commons, (2004), Examination of witnesses (questions 180-199). Minutes of Evidence; London Oct 14, 2004. Available at: http://www.publications.parliament.uk/pa/cm200405/cmselect/ cmhealth/42/4101414.htm[Last accessed in 2007 Apr].
29. Sharp D., (1998), A ghostly crew (Letter), Lancet, 351, p1076.
30. Shashok K., Jacobs A., (2007), Who's watching whose ethics? Slanted reporting of the medical writer's role in the Neuropsychopharmacology- Cyberonics case, The Write Stuff, 16(1), p33-35.
31. Sykes, J.B. (Ed.), (1985), The Concise Oxford Dictionary, Bombay: Ox Uni Press, Seventh edition 1983, reprinted 1985.
32. Reidenberg J.W., (2001), Unmasking ghost writers, Clin Pharmacol Ther, 70(3), p208-209.
33. WAME, (2005), Ghost Writing Initiated by Commercial Companies. WAME Policy Statements. Available from: http://www.wame.Org/wamestmt.htm#ghost [Last accessed on 2007 May 2].
34. Wager E., Field E.A., Grossman L., (2003), Good publication practice for pharmaceutical companies, Curr Med Res Opin, 19(3), p149-154.
35. Wilde Mathews A., (2005), At medical journals, paid writers play a big role, The Wall Street Journal. Available from: http://www.post-gazette.com/pg/ pp/05347/621668.stm [Last accessed in 2007 Apr].
36. Woolley K.L., (2006a), Goodbye Ghostwriters! How To Work Ethically and Efficiently With Professional medical Writers, Chest, 130, p921-923.
37. Woolley K.L., Ely J.A., Woolley M.J., Findlay L., Lynch F.A., Choi Y., et al., (2006b), Declaration of medical writing assistance in international peer-reviewed publications, JAMA, 296, p932-934.